Thymosin Alpha-1: An Immune-Regulatory Peptide for In Vitro Research

What is Thymosin Alpha-1?

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide derived from thymic hormones involved in immune regulation. It plays a crucial role in modulating innate and adaptive immune responses, enhancing the activity of T-cells, dendritic cells, and natural killer (NK) cells. Due to its immunomodulatory properties, Tα1 is extensively studied for its potential in boosting immune responses against infections, cancers, and immunodeficiency states. In research, it serves as a valuable tool for investigating immune cell activation, cytokine production, and immune system balance.

Chemical Structure and Exact Amino Acid Sequence

Exact Sequence:

Ac – Ser – Asp – Ser – Ser – Leu – Gly – Gln – Asp – Arg – Lys – Gly – Gln – Asp – Val – Gly – Glu – Ala – Gly – Leu – Ile – Leu – Lys – Glu – Ala – Ser – Gln – Glu – Se

Structural and Chemical Details:

• CAS Number: 208063-73-4 
• Molecular Formula: C134H212N36O42S2 
• Molecular Weight: Approximately 3105 Da 
• Chemical Modifications: 
  • The N-terminal acetylation (Ac-) confers stability and enhances activity.

Thymosin Alpha-1 is a peptide composed of amino acids linked in a specific sequence, with the acetylation protecting the N-terminus, increasing resistance to enzymatic degradation, and facilitating better activity in biological systems.

Mechanisms of Action

Thymosin Alpha-1 exhibits its immunomodulatory effects through several mechanisms:

• Enhancement of T-cell Function:

Stimulates T-lymphocyte activity, proliferation, and cytokine production, especially interferon-gamma and interleukins, promoting adaptive immunity.

• Activation of Innate Immunity:

Increases the activity of natural killer (NK) cells and dendritic cells, improving the body’s initial response to pathogens and tumor cells.

• Cytokine Regulation:

Balances pro- and anti-inflammatory cytokines, modulating immune responses to prevent excessive inflammation or immune suppression.

• Antiviral and Antitumor Effects:

Induces interferon production and enhances cytotoxic responses, aiding in control of viral infections and cancer progression.

Research & Applications

Current In Vitro Research Focus:

• Investigating immune cell activation, cytokine profiles, and pathogen response modulation.
• Exploring its potential as an adjuvant in vaccine development.
• Studying its effects on immune cell proliferation and functional activity.

Potential Future Directions:

• Therapeutic Utility:

Further studies to establish its efficacy and safety as a clinical immunomodulator in infectious, oncologic, and autoimmune diseases.

• Mechanistic Insights:

Deeper exploration into receptor interactions and downstream signaling pathways.

• Combination Therapy:

Examining synergistic effects with antiviral agents, cancer immunotherapies, or other immune stimulants.

• Safety & Regulatory Studies:

Long-term safety evaluations for potential therapeutic use.

Scientific References and Further Reading

• Miller, R. et al. (2021). “Thymosin Alpha-1: Mechanisms of Immune Modulation.” Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.734243
• Cerrone, M. et al. (2020). “Therapeutic Potentials of Thymosin Alpha-1 in Cancer and Infectious Diseases.” Immunotherapy. https://doi.org/10.2217/imt-2020-0014
• Kuroda, T. et al. (2019). “In Vitro Effects of Thymosin Alpha-1 on Immune Cells.” Journal of Immunological Methods. https://doi.org/10.1016/j.jim.2019.112650

Disclaimer

This product is intended for research purposes only. It is not approved for human or veterinary use, nor is it intended for clinical, diagnostic, or therapeutic applications. All research must comply with applicable local laws and institutional guidelines. Misuse of this compound for human consumption is strictly prohibited.